Chimin(SH:603222)2023-04-27 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥222,593,735.45, a decrease of 22.03% compared to the same period last year[2] - Net profit attributable to shareholders was ¥33,728,551.42, down 52.28% year-on-year[2] - Basic earnings per share decreased by 60.00% to ¥0.06[2] - The net cash flow from operating activities was ¥33,603,831.24, representing a decline of 69.57%[2] - The decline in net profit was primarily due to a decrease in the export volume of safety syringes[5] - Total operating costs for Q1 2023 were CNY 180,569,449.78, down from CNY 210,223,759.68 in Q1 2022, representing a reduction of approximately 14.1%[15] - The total comprehensive income for Q1 2023 was CNY 44,344,907.54, compared to CNY 72,996,128.67 in Q1 2022, indicating a decrease of 39.2%[16] - The company reported a decrease in sales revenue from CNY 319,525,005.26 in Q1 2022 to CNY 218,159,958.69 in Q1 2023, a decline of 31.7%[17] - The financial expenses for Q1 2023 were CNY 5,048,661.07, down from CNY 7,615,572.35 in Q1 2022, showing a decrease of 33.4%[15] - The company recorded a net investment loss of CNY -3,575.85 in Q1 2023, compared to a profit of CNY 9,849,463.05 in Q1 2022[15] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,633,081,701.86, a decrease of 2.98% from the end of the previous year[3] - The company's total assets as of March 31, 2023, amounted to CNY 2,633,081,701.86, down from CNY 2,714,060,425.59 at the end of 2022, reflecting a decrease of about 3%[12] - The total current assets decreased to CNY 970,900,978.68 from CNY 1,046,444,861.54, representing a decline of approximately 7%[10] - The total non-current assets slightly decreased to CNY 1,662,180,723.18 from CNY 1,667,615,564.05, indicating a reduction of about 0.3%[11] - The company's total liabilities decreased to CNY 814,314,148.11 from CNY 939,637,779.38, a decline of approximately 13%[12] - The total equity attributable to shareholders increased to CNY 1,741,485,932.78 from CNY 1,706,949,742.99, reflecting an increase of about 2%[12] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 39,665[6] - The largest shareholder, Shuangge Group Co., Ltd., held 127,983,520 shares, accounting for 23.82% of the total shares[7] - The company completed the registration of 60,196,560 new shares from a non-public offering, increasing the total number of shares to 537,237,415[9] - The company plans to implement a stock option incentive plan for 2023, pending approval from the shareholders' meeting[9] Cash Flow - Cash and cash equivalents decreased significantly to CNY 311,618,920.40 from CNY 649,306,426.64, a drop of approximately 52%[10] - The net cash flow from operating activities for Q1 2023 was CNY 33,603,831.24, a decline of 69.6% from CNY 110,443,571.72 in Q1 2022[18] - The company reported a net cash outflow from investing activities of CNY -279,014,339.17 in Q1 2023, compared to CNY -78,419,068.25 in Q1 2022[18] - Total cash inflow from financing activities was $99,422,400, a decrease from $101,573,975.50 in the previous period[19] - Cash outflow from financing activities totaled $187,695,547.99, compared to $87,625,913.01 previously, indicating a significant increase[19] - Net cash flow from financing activities was -$88,273,147.99, contrasting with a positive $13,948,062.49 in the prior period[19] - The net increase in cash and cash equivalents was -$334,682,506.24, compared to an increase of $45,235,910.94 previously[19] - The ending balance of cash and cash equivalents was $301,043,420.40, down from $306,438,419.83 in the previous period[19] Research and Development - Research and development expenses decreased to CNY 6,259,247.57 in Q1 2023 from CNY 7,845,210.89 in Q1 2022, reflecting a reduction of 20.2%[15] Accounting Standards - The company has not adopted new accounting standards or interpretations for the current year[19]